BRIEF published on 04/09/2024 at 00:05, 1 year 11 months ago Idaho Governor Vetoes Bill to Allow Gold and Silver in State Reserves Gold And Silver Idaho Financial Stability Sound Money Defense League Senate Bill 1314
BRIEF published on 04/09/2024 at 00:05, 1 year 11 months ago Renowned Military Ophthalmologist Dr. Gregory Bryant Giles Joins LasikPlus Lexington Patient Care Dr. Gregory Bryant Giles LasikPlus Lexington Laser Refractive Surgery Military Ophthalmology
BRIEF published on 04/08/2024 at 23:35, 1 year 11 months ago Inspire Veterinary Partners Reports Stimulating Growth in 2023 Financial Outcomes Inspire Veterinary Partners Operational Efficiency Acquisitions Financial Results 2023 Pet Health Sector
BRIEF published on 04/08/2024 at 23:30, 1 year 11 months ago Guanajuato Silver Reports Year-End 2023 Financial Results Financial Results Guanajuato Silver Production Increase Silver Mining Corporate Performance
BRIEF published on 04/08/2024 at 23:25, 1 year 11 months ago Ur-Energy Inc. Welcomes New Board Members and Announces Upcoming Retirements New Board Members Ur-Energy Inc. Corporate Governance Executive Leadership Nuclear Power
BRIEF published on 04/08/2024 at 23:20, 1 year 11 months ago Data4Cure to Present Key Research at AACR 2024 Cancer Research Immunotherapy AACR 2024 Data4Cure Biomedical Data
BRIEF published on 04/08/2024 at 23:17, 1 year 11 months ago Biophytis Reports 2023 Financial Results and Business Updates Biophytis Financial Results 2023 Sarcopenia BIO101 COVID-19 Treatment
BRIEF published on 04/08/2024 at 23:15, 1 year 11 months ago Biophytis Initiates Phase 2 Clinical Study for Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 GLP-1 Receptor Agonists OBA Phase 2 Study
BRIEF published on 04/08/2024 at 23:09, 1 year 11 months ago Biophytis announces its 2023 financial results and provides an update on its activities Biophytis Funding Clinical Development 2023 Financial Results BIO101
BRIEF published on 04/08/2024 at 23:05, 1 year 11 months ago Biophytis Announces Phase 2 Clinical Study in Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 OBA Phase 2 Clinical Study GLP-1 Receptor Agonists
Published on 03/13/2026 at 00:30, 10 hours 58 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Published on 03/12/2026 at 22:55, 12 hours 33 minutes ago Faraday Copper Reports 2025 Financial Results
Published on 03/12/2026 at 22:15, 13 hours 13 minutes ago Avidian Gold Announces the Appointment of a New Director
Published on 03/12/2026 at 22:00, 13 hours 28 minutes ago Onco-Innovations Announces Closing of Private Placement
Published on 03/12/2026 at 21:30, 13 hours 58 minutes ago Loop Industries to Attend the 38th Annual ROTH Conference, March 22-24, 2026
Published on 03/13/2026 at 11:05, 22 minutes ago Alimentaria+Hostelco 2026 reinforces its leadership in a historic edition
Published on 03/13/2026 at 09:32, 1 hour 55 minutes ago Klöckner & Co SE Management and Supervisory Boards reiterate recommendation to accept Worthington Steel takeover offer
Published on 03/13/2026 at 09:00, 2 hours 27 minutes ago Original-Research: Netfonds AG (von NuWays AG): SELL
Published on 03/13/2026 at 09:00, 2 hours 27 minutes ago Original-Research: MLP SE (von NuWays AG): BUY
Published on 03/13/2026 at 09:00, 2 hours 27 minutes ago [MWC 2026] GlobalData Releases a White Paper on Voice Evolution in the AI Era
Published on 03/13/2026 at 07:30, 3 hours 58 minutes ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 17 hours 28 minutes ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 20 hours 21 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 1 day ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 1 day 3 hours ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
